Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-03-18Short-course Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at Interval Debulking Surgery for High Tumor Burden Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2021-03-17HORIZONS: a Cohort Study to Explore Recovery of Health and Well-being in Adults Diagnosed With Cancer
-
CLINICAL_TRIALS study record update · 2021-03-10A Phase 2 Randomized, Multi-Centre Study to Investigate the Efficacy and Tolerability of a Second Maintenance Treatment in Patients With Platinum Sensitive Relapsed Epithelial Ovarian Cancer, Who Have Previously Received PARP Inhibitor Maintenance Treatment
-
CLINICAL_TRIALS study record update · 2021-03-09A Phase 1 Study of SY-1365, a Selective CDK7 Inhibitor, in Adult Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2021-03-08Real-life Use of Niraparib in a Patient Access Program in Norway
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-02-25A Randomized Open Label Phase II Study of Weekly Gemcitabine Plus Pazopanib Versus Weekly Gemcitabine Alone in the Treatment of Patients With Persistent or Relapsed Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma
-
CLINICAL_TRIALS study record update · 2021-02-21A Phase II Open-Label Study of NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2021-02-11Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2021-02-10Multicenter Randomized Study Comparing Neo Adjuvant Chemotherapy for Patients Managed for Ovarian Cancer With or Without a Connected Prehabilitation Program
-
CLINICAL_TRIALS study record update · 2021-02-10Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2021-02-10Sentinel Lymph Node Assessment In Ovarian Cancer - Turkish Gynecologic Oncology Group Study (TRSGO-SLN-005)
-
CLINICAL_TRIALS study record update · 2021-02-08Double-blind, Placebo-controlled Multicenter Phase II Trial to Evaluate the Efficacy and Safety of Romiplostim for the Treatment of Chemotherapy-induced Thrombocytopenia in Subjects With Relapsed Ovarian Cancer (2nd or Further Line)
-
CLINICAL_TRIALS study record update · 2021-02-02Ovarian Malignancy Incidence in Premenopausal Women Who Were at Moderate Risk for Malignancy by Risk of Malignancy Index With Low CA 125.(Retrospective Study)
-
CLINICAL_TRIALS study record update · 2021-02-02Phase I Trial of Intraperitoneal Adenoviral p53 Gene Therapy in Patients With Advanced Recurrent or Persistent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2021-01-27Pilot Study of Durvalumab (MEDI4736) in Combination With Vigil in Advanced Women's Cancers
-
CLINICAL_TRIALS study record update · 2021-01-26An Open Label Phase I Study to Evaluate the Safety and Tolerability of a Modified Vaccinia Ankara (MVA) Based Vaccine Modified to Express Brachyury and T-Cell Costimulatory Molecules (MVA Brachyury-TRICOM)
-
CLINICAL_TRIALS study record update · 2021-01-20PITCHER (Peritoneal Carcinomatosis Heterogeneity)
-
CLINICAL_TRIALS study record update · 2021-01-20A Real-world Study of Clinical Markers for PARP Inhibitors in Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2021-01-20The nCYT Study: A Powered Study to Evaluate the Sensitivity and Specificity of Cytological Evaluation of Fallopian Tube Samples Collected by the Cytuity in Determining the Presence of Malignancy
-
CLINICAL_TRIALS study record update · 2021-01-15A Prospective Randomized Multicentre Trial for Lymphadenectomy in Early-stage Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-12-28A Phase Ila Exploratory 2-stage Design Study of CPC634 (CriPec® Docetaxel) Monotherapy in Subjects With Platinum Resistant Ovarian Cancer.
-
CLINICAL_TRIALS study record update · 2020-12-19A Phase II Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Carcinoma
-
CLINICAL_TRIALS study record update · 2020-12-17A Randomized, Parallel Group, Open-label, Active Controlled, Multicenter Phase III Trial of Patupilone (EPO906) Versus Pegylated Liposomal Doxorubicin in Taxane/Platinum Refractory/Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian or Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2020-12-10Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in the Treatment of Platinum-sensitive Recurrent Ovarian Cancer: a Multicenter, Open, Phase 2 Clinical Study
-
CLINICAL_TRIALS study record update · 2020-12-08Phase 2/3 Study of Masitinib in Combination With Gemcitabine Versus Gemcitabine Alone in Advanced/Metastatic Epithelial Ovarian Cancer Patients in Second Line Being Refractory to First Line Platinum Treatment or in Third Line